# Impact of a Pharmaceutical Care Model in the Management of Chronic Myeloid Leukemia Patients

> **NCT03090477** · NA · COMPLETED · sponsor: **UCSI University** · enrollment: 129 (actual)

## Conditions studied

- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Medication Adherence

## Interventions

- **BEHAVIORAL:** Pharmaceutical care and adherence aids

## Key facts

- **NCT ID:** NCT03090477
- **Lead sponsor:** UCSI University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-24
- **Primary completion:** 2018-06-24
- **Final completion:** 2019-01-31
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2019-04-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03090477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03090477, "Impact of a Pharmaceutical Care Model in the Management of Chronic Myeloid Leukemia Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03090477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*